Alzheimer's disease
A new case study published in Alternative Therapies In Health and Medicine has found that Ayurvedic interventions can aid in slowing cognitive decline and improving daily functioning in patients with Alzheimer's disease. The study, led by Sourabh Deshmukh, presents a clinical case study of a 55-year-old male patient
Alzheimer's disease
Despite Alzheimer's disease being diagnosed more frequently in women, a new study has found that men's brains shrink faster than women's as they age. The research, published in the Proceedings of the National Academy of Sciences, analyzed over 12,000 brain MRIs from nearly
Alzheimer's disease
As we age, the risks of neurodegenerative disorders like Alzheimer's disease rise, and the brain's volume shrinks in size, losing both grey and white matter over time. A recent study published in PNAS on October 13, 2025, has revealed that the brain's shrinking pace
Associations
A night of musical theatre at The McMillan Theatre in Bridgwater brought together a talented cast with West End experience to raise funds for the Alzheimer's Society. Quinn Baker Productions' charity event, Some Enchanted Evening, celebrated the work of renowned composers and featured a cast that came
Alzheimer's disease
As we age, the risks of neurodegenerative disorders like Alzheimer's disease rise, and the brain's volume shrinks in size, losing both grey and white matter over time. A recent study published in PNAS on October 13, 2025, has revealed that the brain's shrinking pace
Diseases
Recent research has shed light on the role of AMPKa2 in transducing amino acid insufficiency signals to protein synthesis, providing new insights into the pathogenesis of Alzheimer's disease (AD). The study, conducted at Huashan Hospital in Shanghai, China, found that AMPKa2 specifically detects low amino acid levels and
Alzheimer's disease
Recent research has shed light on the role of AMPKa2 in transducing amino acid insufficiency signals to protein synthesis, providing new insights into the pathogenesis of Alzheimer's disease (AD). The study, conducted at Huashan Hospital in Shanghai, China, found that AMPKa2 specifically detects low amino acid levels and
Diseases
Researchers at Brigham and Women's Hospital have made a significant discovery in the field of immunology, developing two CNS-tau-specific monoclonal antibodies that can be used to diagnose and understand the progression of tau-related neurodegenerative diseases such as Alzheimer's disease. The antibodies, LL-T-1-1 and LL-T-1-5, were created
Diseases
Researchers at Peking University have made a significant discovery in the field of Alzheimer's disease research, revealing that the von Hippel-Lindau protein (VHL) plays a crucial role in restricting the progression of the disease. The study, published in the Journal of Molecular Cell Biology, demonstrates that VHL-mediated ubiquitination
Diseases
Alzheimer's disease (AD) research has continued to uncover the underlying mechanisms driving neurodegeneration. Investigators at the University of South Florida have published a groundbreaking study that sheds new light on the role of amyloid-beta (Ab) oligomers in disrupting synaptic function. The study, published in Cell Calcium, reveals that
Alzheimer's disease
Researchers co-led by the Institute for Bioengineering of Catalonia (IBEC) and West China Hospital Sichuan University (WCHSU) have made a groundbreaking discovery in treating Alzheimer's disease with a nanotechnology strategy. Unlike traditional nanomedicine, this approach employs bioactive nanoparticles, known as "supramolecular drugs," which restore the proper
Enzymes
Researchers at the University of Jinan have made a groundbreaking discovery in the field of enzymes and coenzymes. According to their study, published in the journal ChemPhysMater, the combination of (-)-epigallocatechin-3-gallate (EGCG) and ferulic acid (FA) significantly enhances the activity of a-secretase (ADAM10), a protein involved in the pathogenesis
